Not Yet Time To ‘Gamble’ On Ocwen Despite Sharp Decline, Says Oppenheimer
Oppenheimer analyst Ben Chittenden, in a note to investors entitled “If You Want to Gamble, Go to Foxwoods,” said it is “very hard” to fully know the outcome of the cease and desist orders and CFPB lawsuit against Ocwen but they, at the least, push out any potential turn in profitability. While he isn’t ready […]
Samsung Bioepis’ Knockoff Latest Competition For Johnson & Johnson’s Blockbuster, Remicade
Johnson & Johnson (JNJ)’s Remicade earned close to $7 billion last year, making it by far the biggest drug in their portfolio, but the FDA has approved a new knockoff…which may finally start to shift the market dynamics toward greater competition with lower prices. Written by John Carroll (ENDpts.com) The FDA approval was unusual among the […]
TIPping Points?
The Federal Reserve’s complete change last year wasn’t something that happened all at once. There were several hints that a lot was going on behind the scenes that may never become public, including five years (now four) down the road when the full policy transcripts are released to the public. There was more interest in […]
Stocks Rally On Fiscal Policy Progress
The stock market rallied on Thursday as it appears the mini 3% correction is over. As I’ve mentioned, there is a large group of investors who are dying to get into the market. Whenever there is a 5% correction, they plow money into stocks. Because 5% corrections have become rare, these bullish investors preempt them […]
French Presidential Election, Political Risk And Global Economic News
On this week’s episode of Market Week in Review, Investment Strategist Paul Eitelman joins Sophie Antal-Gilbert, program director, advisor insights, to discuss both the French presidential election and UK snap election, as well as the week’s global economic news.
Stifel Tells Investors To Buy SeaWorld, Six Flags
Research firm Stifel started coverage of several amusement park operators with Buy ratings, telling investors that SeaWorld (SEAS) should benefit from its strong management team, while Six Flags’ (SIX) valuation is attractive. SEAWORLD: Analyst Steven Wieczynski says that the stock has a better risk/reward ratio than any other theme park name he covers. The company’s […]
Adamis Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
SAN DIEGO, April 21, 2017 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (Nasdaq: ADMP), a specialty biopharmaceutical company focused on developing and commercializing products in the therapeutic areas of respiratory disease and allergy, announced today the pricing of its previously announced underwritten public offering of 4,285,715 shares of its common stock at a public offering price of […]
